Published in Arch Gen Psychiatry on March 01, 1972
Some of the problems and difficulties associated with clinical studies of antidepressant agents. Br J Clin Pharmacol (1977) 1.08
Predictors of remission in depression to individual and combined treatments (PReDICT): study protocol for a randomized controlled trial. Trials (2012) 1.06
Suicidal ideation and biogenic amines in depression. Indian J Psychiatry (1983) 0.80
Norepinephrine and serotonin metabolism and clinical response to combined imipramine and amitriptyline therapy in depression. Indian J Psychiatry (1991) 0.76
Principles of antidepressant use. Can Fam Physician (1981) 0.75
Physical activity and the healthy mind. Can Med Assoc J (1983) 0.75
The biochemical evaluation of psychotropic drugs. Br J Clin Pharmacol (1976) 0.75
The effect of mianserin on urinary catecholamine excretion in psychiatric patients. Br J Clin Pharmacol (1981) 0.75
Biochemical assessment of antidepressive drugs. Br J Clin Pharmacol (1980) 0.75
Amitriptyline and oxaprotiline in the treatment of hospitalized depressive patients. Clinical aspects, psychophysiology, and drug plasma levels. Eur Arch Psychiatry Neurol Sci (1986) 0.75
Subtypes of depression--diagnosis and medical management. West J Med (1977) 0.75
A simplified routine assay for urinary 3-methoxy-4-hydroxyphenylglycol. J Neural Transm (Vienna) (1997) 0.75
Maintenance phase efficacy of sertraline for chronic depression: a randomized controlled trial. JAMA (1998) 4.48
Catecholamines in attention-deficit hyperactivity disorder: current perspectives. J Am Acad Child Adolesc Psychiatry (1996) 1.89
Cocaine plasma concentration: relation to physiological and subjective effects in humans. Science (1978) 1.37
Biogenic amines and depression. Biochemical and pharmacological separation of two types of depression. Arch Gen Psychiatry (1975) 1.17
Treatment received by depressed patients. JAMA (1982) 1.14
Distinct regional and subcellular localization of adenylyl cyclases type 1 and 8 in mouse brain. Neuroscience (2007) 1.08
The treatment of chronic depression, part 1: study design and rationale for evaluating the comparative efficacy of sertraline and imipramine as acute, crossover, continuation, and maintenance phase therapies. J Clin Psychiatry (1998) 1.05
Behavioral effects of stimulation of the nucleus locus coeruleus in the stump-tailed monkey Macaca arctoides. Brain Res (1976) 1.00
Pituitary adrenal function and depression. An outline for research. Arch Gen Psychiatry (1967) 0.97
Further evaluation of urinary 17-hydroxycorticosteroids in suicidal patients. Arch Gen Psychiatry (1969) 0.96
Adenosine triphosphate--metal--norepinephrine ternary complexes and catecholamine binding. Nature (1965) 0.96
Diverse spore rains and limited local exchange shape fern genetic diversity in a recently created habitat colonized by long-distance dispersal. Ann Bot (2012) 0.93
The timing, specificity and clinical prediction of tricyclic drug effects in depression. Psychol Med (1987) 0.93
Central biogenic amine metabolism in children with the syndrome of chronic multiple tics of Gilles de la Tourette: norepinephrine, serotonin, and dopamine. J Am Acad Child Psychiatry (1979) 0.92
Fluphenazine determination in human plasma by a sensitive gas chromatographic method using nitrogen detector. J Chromatogr Sci (1981) 0.91
Co-ordination chemistry and membrane function with particular reference to the synapse and catecholamine transport. Nature (1965) 0.90
The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine. J Clin Psychiatry (1998) 0.90
Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study. Arch Gen Psychiatry (1984) 0.89
The distribution of protein-bound N-acetylneuraminic acid in subcellular fractions of rat brain. Biochem J (1967) 0.89
Interactions of risk factors in predicting suicide. Am J Psychiatry (1994) 0.89
An improved procedure of 3-methoxy-4-hydroxyphenyl-ethylene glycol determination by gas-liquid chromatography. Anal Biochem (1970) 0.88
Effects of fire ant venom alkaloids on platelet and neutrophil function. Life Sci (1993) 0.88
In vivo studies of the metabolism of norepinephrine in the central nervous system. J Pharmacol Exp Ther (1968) 0.87
A behavioral-biochemical study of lithium treatment. Am J Psychiatry (1968) 0.87
The time course of noradrenergic pre- and postsynaptic activity during chronic desipramine treatment. Eur J Pharmacol (1980) 0.87
Adrenocortical steroid hormones, electrolytes, and the disposition of the catecholamines with particular reference to depressive states. J Psychiatr Res (1972) 0.86
CSF and urinary biogenic amines and metabolites in depression and mania. A controlled, univariate analysis. Arch Gen Psychiatry (1983) 0.86
Can the spread of agriculture in Europe be followed by tracing the spread of the weed Silene latifolia. A RAPD study. Theor Appl Genet (1996) 0.86
Primary affective disorder, clinical state change, and MHPG excretion: a longitudinal study. Arch Gen Psychiatry (1978) 0.85
An exceptional case of tyrosinosis. J Ment Defic Res (1968) 0.85
Dystonic reactions following neuroleptics: time course and proposed mechanisms. Psychopharmacologia (1976) 0.85
Distribution of protein-bound N-acetylneuraminic acid in subcellular particulate fractions prepared from rat whole brain. Biochim Biophys Acta (1969) 0.85
Treatment of chronic depression with sertraline or imipramine: preliminary blinded response rates and high rates of undertreatment in the community. Psychopharmacol Bull (1995) 0.84
Pharmacokinetics of red blood cell phenothiazine and clinical effects. Acute dystonic reactions. Arch Gen Psychiatry (1976) 0.84
Increased ouabain binding after repeated noradrenergic stimulation. Brain Res (1981) 0.83
Drug-induced actions on brain neurotransmitter systems and changes in the behaviors and emotions of depressed patients. Neuropsychopharmacology (1994) 0.83
Mania. Diagnosis, state measurement and prediction of treatment response. J Affect Disord (1985) 0.83
Social behavior of monkeys selectively depleted of monoamines. Science (1971) 0.83
MHPG excretion by patients with affective disorders. Int Pharmacopsychiatry (1974) 0.83
Suicide potential and time perspective. Arch Gen Psychiatry (1970) 0.82
Catecholamine metabolism in anorexia nervosa. Arch Gen Psychiatry (1978) 0.82
Alcoholism and cerebral atrophy. Alcohol Clin Exp Res (1977) 0.81
Evidence against specificity of electrical stimulation of the nucleus locus coeruleus in activating the sympathetic nervous system in the rat. Brain Res (1980) 0.81
A multi-vantaged approach to measurement of behavioral and affect states for clinical and psychobiological research. Psychol Rep (1984) 0.81
Brain catecholamine metabolites and behavior in morphine withdrawal. Eur J Pharmacol (1982) 0.81
Lithium treatment of mania: clinical characteristics, specificity of symptom change, and outcome. Psychiatry Res (1986) 0.81
Effects of amitriptyline and imipramine on brain amine neurotransmitter metabolites in cerebrospinal fluid. Clin Pharmacol Ther (1985) 0.81
A schizophreniform behavioral psychosis mediated by dopamine. Am J Psychiatry (1975) 0.81
CSF monoamine metabolites in mania. Am J Psychiatry (1983) 0.80
Lack of stability of the RDC endogenous subtype in consecutive episodes of major depression. J Affect Disord (1987) 0.80
Estimates of dopamine and serotonin synthesis by the awake human brain. J Neurochem (1980) 0.80
Sex differences in the lifetime prevalence of depression: does varying the diagnostic criteria reduce the female/male ratio? J Affect Disord (1990) 0.80
Metal chelates of L-DOPA for improved replenishment of dopaminergic pools. Brain Res (1976) 0.80
Catecholamine metabolite excretion following intraventricular injection of 6-OH-dopamine. Brain Res (1972) 0.80
Urinary catecholamines in attention-deficit hyperactivity disorder with and without comorbid anxiety. J Am Acad Child Adolesc Psychiatry (1994) 0.79
Attention deficit disorder symptoms and urine catecholamines. Psychiatry Res (1989) 0.79
The metabolism of circulating norepinephrine by human subjects. J Pharmacol Exp Ther (1971) 0.79
Catecholamine metabolism and disposition in healthy and depressed subjects. Arch Gen Psychiatry (1987) 0.79
3-Methoxy-4-hydroxy phenylglycol (MHPG) excretion in depressive states. A pilot study. Arch Gen Psychiatry (1968) 0.79
Calcium function in affective disorders and healthy controls. Biol Psychiatry (1988) 0.79
Concordance of symptoms in recurrent depressive episodes. J Affect Disord (1990) 0.79
In vivo location and destruction of the locus coeruleus in the stumptail macaque (Macaca arctoides). Brain Res (1975) 0.79
3-Methoxy-4-hydroxyphenethyleneglycol production by human brain in vivo. Science (1979) 0.78
Phenothiazine levels in plasma and red blood cells. Their relationship to clinical improvement in schizophrenia. Arch Gen Psychiatry (1980) 0.78
Acute effects of neuroleptics on unmedicated schizophrenic patients and controls. Biol Psychiatry (1993) 0.78
Transfer RNA and the regulation of protein synthesis in rat cerebral cortex during neural development. J Neurochem (1974) 0.78
3-Methoxy-4-hydroxyphenethylene glycol in plasma. Clin Chim Acta (1974) 0.78
Neuroleptic drug levels and therapeutic response: preliminary observations with red blood cell bound butaperazine. Am J Psychiatry (1977) 0.78
Blood levels of haloperidol in schizophrenic patients. J Clin Psychopharmacol (1983) 0.78
Lithium carbonate treatment of mania. Cerebrospinal fluid and urinary monoamine metabolites and treatment outcome. Arch Gen Psychiatry (1987) 0.78
Dihydroxyphenylacetic acid conjugate: natural occurrence and demonstration of probenecid-induced accumulation in rat striatum, olfactory tubercles and frontal cortex. Eur J Pharmacol (1977) 0.78
The identification of fractions enriched in nonmyelinated axons from rat whole brain. Exp Brain Res (1970) 0.78
Effects of chronic dietary lithium on activity and regulation of (Na+,K+)-adenosine triphosphatase in rat brain. Biochem Pharmacol (1980) 0.78
Regional distribution of dopamine metabolites in human and primate brain. Commun Psychopharmacol (1978) 0.78
Brain (Na+, K+)-ATPase and noradrenergic activity: effects of hyperinnervation and denervation on high-affinity ouabain binding. J Neurochem (1982) 0.78
Biochemistry and suicidal behavior in depressed patients. Biol Psychiatry (1986) 0.78
Presynaptic adrenergic receptor sensitivity in depression. The effect of long-term desipramine treatment. Arch Gen Psychiatry (1981) 0.78
Urinary catecholamine metabolites during behavioral changes in a patient with manic-depressive cycles. Science (1973) 0.78
Stimulation of the dorsal noradrenergic dundle and field potentials in the locus coeruleus. Brain Res (1976) 0.78
The occurrence of free vs. conjugated MHPG in non-human and human primate brain. Psychopharmacol Commun (1976) 0.77
Urinary MHPG excretion and treatment with desipramine or amitriptyline: prediction of response, effect of treatment, and methodological hazards. J Clin Psychopharmacol (1983) 0.77
A direct method for studying 3-methoxy-4-hydroxyphenethyleneglycol (MHPG) production by brain in awake animals. Eur J Pharmacol (1977) 0.77
A kinetic study of the disposition of circulating norepinephrine in normal male subjects. J Pharmacol Exp Ther (1970) 0.77
Locus coeruleus stimulation increases noradrenergic metabolite levels in rat spinal cord. Brain Res (1979) 0.77
Hydrocortisone-mediated increase of norepinephrine uptake by brain slices. Science (1971) 0.77
Proceedings: Urinary MHPG excretion in primary affective disorders. Psychopharmacol Bull (1974) 0.77
Catecholamine metabolism, depression and stress. Nature (1971) 0.77
Depressive mania versus agitated depression: biogenic amine and hypothalamic-pituitary-adrenocortical function. Biol Psychiatry (1994) 0.77
Plasma free MHPG and neuroendocrine responses to challenge doses of clonidine in Tourette's syndrome: preliminary report. Life Sci (1981) 0.77
Stress, depression, and mania: relationship between perceived role of stressful events and clinical and biochemical characteristics. Acta Psychiatr Scand (1990) 0.77
Mania: sympathoadrenal function and clinical state. Psychiatry Res (1991) 0.77